
Hyris is a tech-bio company aiming to democratize genetics and health insights. They offer the Hyris System™, a multi-market platform featuring miniaturized qPCR devices and AI-driven cloud-based software solutions, enabling genetic testing in any setting. Operating with a marketplace approach, they foster partnerships with kit developers and distributors to expand access to their genetic testing ecosystem. Their solutions cater to sectors including Healthcare & Diagnostics, Agrifood & Environment, and Research & Academy, with recent news highlighting their role in supporting malaria testing and integration into the Ulisse Biomed group.

Hyris is a tech-bio company aiming to democratize genetics and health insights. They offer the Hyris System™, a multi-market platform featuring miniaturized qPCR devices and AI-driven cloud-based software solutions, enabling genetic testing in any setting. Operating with a marketplace approach, they foster partnerships with kit developers and distributors to expand access to their genetic testing ecosystem. Their solutions cater to sectors including Healthcare & Diagnostics, Agrifood & Environment, and Research & Academy, with recent news highlighting their role in supporting malaria testing and integration into the Ulisse Biomed group.
Founded: 2014
Product: Hyris System — portable miniaturized qPCR devices plus AI-driven cloud software and marketplace
Sectors: Healthcare & Diagnostics, Agrifood & Environment, Research & Academy
Notable investors: Astanor Ventures, Pi Campus
Decentralized molecular diagnostics and genetic testing for clinical, agricultural and environmental applications.
2014
Biotechnology
Series A announced May 27, 2020; Pi Campus participated.
“Astanor Ventures and Pi Campus participated in Series A”